First in Canada: Researchers in London, Ont. treat cancer patient with innovative therapy
A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a neuroendocrine tumours cancer patient using an innovative treatment.
A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a neuroendocrine tumours cancer patient using an innovative treatment.
